These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

218 related items for PubMed ID: 823278

  • 1. Susceptibility of nonfermentative gram-negative bacilli to tobramycin.
    Uwaydah M, Taqi-Eddin AR.
    J Infect Dis; 1976 Aug; 134 Suppl():S28-32. PubMed ID: 823278
    [Abstract] [Full Text] [Related]

  • 2. Emergence of gentamicin-resistant bacteria: experience with tobramycin therapy of infections due to gentamicin-resistant organisms.
    Moellering RC, Wennersten C, Kunz LJ.
    J Infect Dis; 1976 Aug; 134 Suppl():S40-9. PubMed ID: 972284
    [Abstract] [Full Text] [Related]

  • 3. In vitro activity of aminoglycosides against clinical isolates of Acinetobacter baumannii complex and other nonfermentative Gram-negative bacilli causing healthcare-associated bloodstream infections in Taiwan.
    Liu JY, Wang FD, Ho MW, Lee CH, Liu JW, Wang JT, Sheng WH, Hseuh PR, Chang SC.
    J Microbiol Immunol Infect; 2016 Dec; 49(6):918-923. PubMed ID: 26364729
    [Abstract] [Full Text] [Related]

  • 4. Gentamicin and tobramycin--an in vitro comparison using 1400 clinical isolates.
    Forgan-Smith WR, Andrew JH, McSweeney RJ.
    Pathology; 1976 Jul; 8(3):195-9. PubMed ID: 826868
    [Abstract] [Full Text] [Related]

  • 5. ["In vitro" activity of gentamicin, sisomicin and tobramycin against "pseudomonas aeruginosa" strains from hospital sources (author's transl)].
    Campello C, Crevatin E.
    Ann Sclavo; 1977 Jul; 19(3):437-45. PubMed ID: 415672
    [Abstract] [Full Text] [Related]

  • 6. Letter: Activities of tobramycin and amikacin against gentamicin-resistant gram-negative bacilli.
    Houang ET, McKay-Ferguson E.
    Lancet; 1976 Feb 21; 1(7956):423-4. PubMed ID: 55682
    [No Abstract] [Full Text] [Related]

  • 7. [Comparative activity of habekacin and 4 other aminoglycosides against gram-negative bacilli. Evolution of resistance].
    Reynaud AE, Coude du Foresto B, Derriennic M, Courtieu AL.
    Pathol Biol (Paris); 1988 May 21; 36(5):435-8. PubMed ID: 3136424
    [Abstract] [Full Text] [Related]

  • 8. Comparative in vitro activity of tobramycin, gentamicin, kanamycin, colistin, carbenicillin, and ticarcillin and clinical isolates of Pseudomonas aeruginosa: epidemiological and therapeutic implications.
    Dulong de Rosnay HL, Grimont PA, Dessaut B, Lesgouarres MT.
    J Infect Dis; 1976 Aug 21; 134 Suppl():S50-6. PubMed ID: 823279
    [Abstract] [Full Text] [Related]

  • 9. Activity of netilmicin compared with those of gentamicin and tobramycin against enterobacteria and Pseudomonas aeruginosa.
    Chadwick P, Salmon S, Taylor B.
    Antimicrob Agents Chemother; 1977 Sep 21; 12(3):301-7. PubMed ID: 410361
    [Abstract] [Full Text] [Related]

  • 10. Susceptibility of current clinical isolates of Pseudomonas aeruginosa and enteric gram-negative bacilli to amikacin and other aminoglycoside antibiotics.
    Dámaso D, Moreno-López M, Martínez-Beltrán J, García-Iglesias MC.
    J Infect Dis; 1976 Nov 21; 134 SUPPL():S394-90. PubMed ID: 825591
    [Abstract] [Full Text] [Related]

  • 11. [Comparison between the activity of 2 amino-glycoside antibiotics, tobramycin and gentamicin on gram negative bacteria in vitro].
    De Rosa F, Tassi C, Stagni GR.
    Ann Sclavo; 1974 Nov 21; 16(1):65-72. PubMed ID: 4214247
    [No Abstract] [Full Text] [Related]

  • 12. Pseudomonas aeruginosa resistant to aminoglycosides: an assessment of the currently used methods of disk diffusion and dilution susceptibility.
    Ismaeel NA.
    Microbios; 1991 Nov 21; 66(268-269):197-204. PubMed ID: 1907714
    [Abstract] [Full Text] [Related]

  • 13. Tobramycin, amikacin, sissomicin, and gentamicin resistant Gram-negative rods.
    Drasar FA, Farrell W, Maskell J, Williams JD.
    Br Med J; 1976 Nov 27; 2(6047):1284-7. PubMed ID: 1000196
    [Abstract] [Full Text] [Related]

  • 14. In vitro activities of quinolones, beta-lactams, tobramycin, and trimethoprim-sulfamethoxazole against nonfermentative gram-negative bacilli.
    Fass RJ, Barnishan J, Solomon MC, Ayers LW.
    Antimicrob Agents Chemother; 1996 Jun 27; 40(6):1412-8. PubMed ID: 8726011
    [Abstract] [Full Text] [Related]

  • 15. Susceptibility of Pseudomonas aeruginosa to tobramycin or gentamicin alone and combined with carbenicillin.
    Anderson EL, Gramling PK, Vestal PR, Farrar WE.
    Antimicrob Agents Chemother; 1975 Sep 27; 8(3):300-4. PubMed ID: 810083
    [Abstract] [Full Text] [Related]

  • 16. [Non-fermentative gram-negative bacilli: their distribution to clinical materials and antibiotic susceptibility (author's transl)].
    Akalin HE, Baykal M.
    Mikrobiyol Bul; 1980 Jan 27; 14(1):21-6. PubMed ID: 7453583
    [Abstract] [Full Text] [Related]

  • 17. Cross-resistance of Pseudomonas to gentamicin and tobramycin.
    Brusch JL, Barza M, Bergeron MG, Weinstein L.
    Antimicrob Agents Chemother; 1972 Mar 27; 1(3):280-1. PubMed ID: 4625628
    [Abstract] [Full Text] [Related]

  • 18. Antimicrobial susceptibility of gentamicin-resistant Pseudomonas aeruginosa.
    Yu PK, Washington JA.
    Mayo Clin Proc; 1977 Dec 27; 52(12):802-5. PubMed ID: 413013
    [Abstract] [Full Text] [Related]

  • 19. Antibacterial activity of ticarcillin, tobramycin and gentamicin alone and in combination against Pseudomonas aeruginosa in vitro.
    Ullmann U.
    Chemotherapy; 1977 Dec 27; 23(5):314-23. PubMed ID: 409590
    [Abstract] [Full Text] [Related]

  • 20. Pseudomonas aeruginosa and Acinetobacter calcoaceticus: in vitro susceptibility of 150 clinical isolates to five beta-lactam antibiotics and tobramycin.
    Dibb WL, Asphaug Kjellevold V, Digranes A.
    Chemotherapy; 1983 Dec 27; 29(5):332-6. PubMed ID: 6311491
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.